Aurinia Pharmaceuticals, Inc. (AUPH)

14.31 +0.10 (+0.70%) USD  |  NASDAQ  |  Mar 03, 13:35
More

Aurinia Pharmaceuticals Other Income and Expenses (Quarterly)

Other Income and Expenses (Quarterly) Chart

View Other Income and Expenses (Quarterly) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Income and Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Income and Expenses (Quarterly) Range, Past 5 Years

View Other Income and Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Income and Expenses (Quarterly) Benchmarks

View Other Income and Expenses (Quarterly) Benchmarks
Start Trial
Xenon Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
ProMIS Neurosciences, Inc. Upgrade